BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 28, 2002
View Archived Issues
FDA Grants Corixa's Appeal; Bexxar Will Go Before ODAC
Corixa Corp. won an appeal against an FDA decision issued earlier this year that required additional clinical trials in order to market the cancer drug Bexxar. (BioWorld Today)
Read More
Exact Sciences, LabCorp Enter Molecular Diagnostics Alliance
Read More
'Smart Bomb' Nanoparticle, Killer Gene, Canny Receptor Team Up To Starve Tumor Of Blood Supply
Read More
BioDelivery Raises $10.5M In IPO To Fund Delivery Technology
Read More
Other News To Note
Read More